$BCDA

$0.90▲ +5.9% YTD

6 SEC 13D/G filings tracked · Last updated Nov 9, 2026

Filing History

News

BCDA ▲ +5.9% - BioCardia, Inc.

CP $0.90▲ +5.9%Nov 9, 2026 · ThinkSabio Blog

$BCDA - BioCardia to Host Q3 2026 Financial Results and Corporate Update Conference Call on November 12, 2026…

News

BCDA ▲ +1.1% - BioCardia, Inc.

CP $0.92▲ +1.1%Nov 6, 2026 · ThinkSabio Blog

$BCDA - BioCardia Completes Clinical Consultation Process with Japan's PMDA for CardiAMP Cell Therapy System, Advancing Toward Submission of Marketing…

News

BCDA ▲ +2.8% - BioCardia, Inc.

CP $1.10▲ +2.8%Oct 7, 2026 · ThinkSabio Blog

$BCDA - BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting…

News

BCDA ▼ -1.0% - BioCardia, Inc.

CP $1.00▲ -1.0%Oct 1, 2026 · ThinkSabio Blog

$BCDA - BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter…

News

BCDA ▼ -1.9% - BioCardia, Inc.

CP $1.03▲ -1.9%Sep 23, 2026 · ThinkSabio Blog

$BCDA - BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission…

News

BCDA ▼ -0.9% - BioCardia, Inc.

CP $1.09▲ -0.9%Sep 10, 2026 · ThinkSabio Blog

$BCDA - BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference…